» Articles » PMID: 39702357

Asperuloside Alleviates Osteoporosis by Promoting Autophagy and Regulating Nrf2 Activation

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2024 Dec 20
PMID 39702357
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoporosis is a metabolic bone disease that has a common occurrence in postmenopausal women. Asperuloside (ASP) has been reported to exert anti-inflammatory and anti-oxidative effects in numerous diseases, such as rheumatoid arthritis and acute lung injury. However, whether ASP plays a role in osteoporosis has not been addressed.

Methods: In vivo, ovariectomy (OVX) was used to induce mouse osteoporosis. Then, the mice were treated with 20 and 40 mg/kg ASP. In vitro, MC3T3-E1 cells were treated with 0, 1, 10, 20, 40 and 80 µM ASP. We chose 20 and 40 µM for further experiments due to no significant effects on cell viability.

Results: The data indicated that ASP reduced osteoporosis in OVX mice and promoted osteogenic differentiation and mineralization in MC3T3-E1 cells. In addition, we explored that ASP protected against osteoporosis via inducing autophagy and activating Nrf2.

Conclusion: ASP alleviates OVX-induced osteoporosis by promoting autophagy and regulating Nrf2 activation.

Citing Articles

Therapeutic potential of total flavonoids of Rhizoma Drynariae: inhibiting adipogenesis and promoting osteogenesis via MAPK/HIF-1α pathway in primary osteoporosis.

Su H, Liu L, Yan Z, Guo W, Huang G, Zhuang R J Orthop Surg Res. 2025; 20(1):260.

PMID: 40069718 PMC: 11895304. DOI: 10.1186/s13018-025-05665-8.


Three signalling pathways for iron overload in osteoporosis: a narrative review.

Zou L, Chen G, Rong Y, Tang C, Lv X, Fan Y J Orthop Surg Res. 2025; 20(1):186.

PMID: 39979989 PMC: 11844007. DOI: 10.1186/s13018-025-05588-4.


Efficacy and safety of sequential therapy for primary osteoporosis with bone formation promoters followed by bone resorption inhibitors: a meta-analysis.

Liu Y, Liu X, Wu Y, Luo T J Orthop Surg Res. 2025; 20(1):147.

PMID: 39920732 PMC: 11803957. DOI: 10.1186/s13018-025-05545-1.


Effects of traditional Chinese medicine Zuo-Gui-Wan on gut microbiota in an osteoporotic mouse model.

Li J, HaomingYou , Hu Y, Li R, Ouyang T, Ran Q J Orthop Surg Res. 2025; 20(1):128.

PMID: 39891262 PMC: 11786422. DOI: 10.1186/s13018-025-05504-w.


Ferrostatin-1 inhibits osteoclast differentiation and prevents osteoporosis by suppressing lipid peroxidation.

Xu W, Lv S, Wang X, Song C, Xi C, Yan J J Orthop Surg Res. 2025; 20(1):117.

PMID: 39885539 PMC: 11780991. DOI: 10.1186/s13018-025-05544-2.

References
1.
Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M . Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021; 16(1):533. PMC: 8393477. DOI: 10.1186/s13018-021-02678-x. View

2.
Song S, Guo Y, Yang Y, Fu D . Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022; 237:108168. DOI: 10.1016/j.pharmthera.2022.108168. View

3.
Chen Y, Xu S, Lu Y, Chen S, Du X, Hou S . Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-κB pathways. Chem Biol Interact. 2021; 344:109512. DOI: 10.1016/j.cbi.2021.109512. View

4.
Xiong Y, Huang C, Shi C, Peng L, Cheng Y, Hong W . Quercetin suppresses ovariectomy-induced osteoporosis in rat mandibles by regulating autophagy and the NLRP3 pathway. Exp Biol Med (Maywood). 2024; 248(23):2363-2380. PMC: 10903250. DOI: 10.1177/15353702231211977. View

5.
Li X, Xu J, Dai B, Wang X, Guo Q, Qin L . Targeting autophagy in osteoporosis: From pathophysiology to potential therapy. Ageing Res Rev. 2020; 62:101098. DOI: 10.1016/j.arr.2020.101098. View